Literature DB >> 20616728

The impact of Th17 cells on transplant rejection and the induction of tolerance.

Sebastiaan Heidt1, David San Segundo, David San, Radhika Chadha, Kathryn J Wood.   

Abstract

PURPOSE OF REVIEW: This review aims to provide an overview of the latest evidence for the involvement of Th17 cells in the rejection of solid organ allografts. It will also consider the implications of the relationship between the differentiation pathways of Th17 and regulatory T cells (Tregs), as well as their plasticity in the context of transplantation tolerance. RECENT
FINDINGS: In the absence of the Th1 lineage in vivo, Th17 cells are capable of rejecting cardiac allografts, showing the capacity of Th17 cells to cause allograft rejection, at least in experimental models. Th17 cells are relatively unsusceptible to suppression by Tregs, although this may be context dependent. Furthermore, addition of inflammatory signals to a Treg-inducing environment leads to Th17 development and established Tregs can be converted to Th17 cells under inflammatory conditions.
SUMMARY: The capacity of Th17 cells to cause allograft rejection is becoming increasingly clear. However, the role and contribution of Th17 cells in allograft rejection in the presence of the full orchestra of T helper cells remains elusive. The apparent resistance of Th17 to be suppressed by Tregs may pose a hurdle for effective immunosuppression and tolerance inducing protocols. Furthermore, the close developmental pathways of Th17 and Tregs and the ability of Tregs to convert into Th17 cells in the presence of inflammatory signals may impede the establishment of specific unresponsiveness to donor alloantigens in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20616728      PMCID: PMC3095085          DOI: 10.1097/MOT.0b013e32833b9bfb

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  55 in total

Review 1.  IL-17 and Th17 Cells.

Authors:  Thomas Korn; Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

2.  Transforming growth factor-beta induces development of the T(H)17 lineage.

Authors:  Paul R Mangan; Laurie E Harrington; Darrell B O'Quinn; Whitney S Helms; Daniel C Bullard; Charles O Elson; Robin D Hatton; Sharon M Wahl; Trenton R Schoeb; Casey T Weaver
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

3.  Molecular antagonism and plasticity of regulatory and inflammatory T cell programs.

Authors:  Xuexian O Yang; Roza Nurieva; Gustavo J Martinez; Hong Soon Kang; Yeonseok Chung; Bhanu P Pappu; Bhavin Shah; Seon Hee Chang; Kimberly S Schluns; Stephanie S Watowich; Xin-Hua Feng; Anton M Jetten; Chen Dong
Journal:  Immunity       Date:  2008-06-26       Impact factor: 31.745

4.  CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice.

Authors:  Bryna E Burrell; Keri Csencsits; Guanyi Lu; Svetlana Grabauskiene; D Keith Bishop
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

5.  Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes.

Authors:  Miguel Ascon; Dolores B Ascon; Manchang Liu; Chris Cheadle; Chaitali Sarkar; Lorraine Racusen; Heitham T Hassoun; Hamid Rabb
Journal:  Kidney Int       Date:  2008-12-17       Impact factor: 10.612

6.  Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells.

Authors:  Hans J P M Koenen; Ruben L Smeets; Paul M Vink; Esther van Rijssen; Annemieke M H Boots; Irma Joosten
Journal:  Blood       Date:  2008-07-10       Impact factor: 22.113

7.  Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes.

Authors:  Hayley G Evans; Tesha Suddason; Ian Jackson; Leonie S Taams; Graham M Lord
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

8.  Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo.

Authors:  Suresh Radhakrishnan; Rosalyn Cabrera; Erin L Schenk; Pilar Nava-Parada; Michael P Bell; Virginia P Van Keulen; Ronald J Marler; Sara J Felts; Larry R Pease
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

Review 9.  Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity?

Authors:  M I Koenders; W B van den Berg
Journal:  Clin Exp Immunol       Date:  2009-11-11       Impact factor: 4.330

10.  All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.

Authors:  Yang-Hau Van; Wen-Hui Lee; Serina Ortiz; Mi-Heon Lee; Han-Jun Qin; Chih-Pin Liu
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

View more
  37 in total

1.  Aqueous extract of Caesalpinia sappan decelerates allograft rejection by inducing imbalance between CD4(+) CD25(+) T cells and Th17 cells.

Authors:  Chunxia Li; Hui Zhang; Dongqin Gao; Qun Ma; Zhihua Li; Jun Dai; Mingyan Zhang; Chuanping Si
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Absence of MyD88 signaling induces donor-specific kidney allograft tolerance.

Authors:  Huiling Wu; Gerda A Noordmans; Maya R O'Brien; Jin Ma; Cathy Y Zhao; Geoff Y Zhang; Tony K T Kwan; Stephen I Alexander; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 10.121

Review 3.  The parallel paradigm between intestinal transplant inflammation and inflammatory bowel disease.

Authors:  Leonid Belyayev; Katrina Loh; Thomas M Fishbein; Alexander Kroemer
Journal:  Curr Opin Organ Transplant       Date:  2019-04       Impact factor: 2.640

4.  Combined use of pharmacophoric models together with drug metabolism and genotoxicity "in silico" studies in the hit finding process.

Authors:  Ma José Jerez; Miguel Jerez; Coral González-García; Sara Ballester; Ana Castro
Journal:  J Comput Aided Mol Des       Date:  2013-01-08       Impact factor: 3.686

5.  Trichinella spiralis infection changes immune response in mice performed abdominal heterotopic cardiac transplantation and prolongs cardiac allograft survival time.

Authors:  Gengguo Deng; Ronghai Deng; Jianping Yao; Bing Liao; Yinghua Chen; Zhongdao Wu; Hongxing Hu; Xingwang Zhou; Yi Ma
Journal:  Parasitol Res       Date:  2015-10-19       Impact factor: 2.289

Review 6.  TH17 cells in human recurrent pregnancy loss and pre-eclampsia.

Authors:  Binqing Fu; Zhigang Tian; Haiming Wei
Journal:  Cell Mol Immunol       Date:  2014-07-14       Impact factor: 11.530

7.  BATF inhibition prevent acute allograft rejection after cardiac transplantation.

Authors:  Bo Yang; Fan He; Chen Dai; Rumeng Tan; Dongxia Ma; Zhimin Wang; Bo Zhang; Jincheng Feng; Lai Wei; Hua Zhu; Zhishui Chen
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

8.  Tocilizumab promotes corneal allograft survival in rats by modulating Treg-Th17 balance.

Authors:  Xiao-Song Wu; Xiao-Li Lu; Jing Wu; Ming Ma; Jian Yu; Zhen-Yu Zhang
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

9.  The imbalance of T helper 17/regulatory T cells and memory B cells during the early post-transplantation period in peripheral blood of living donor liver transplantation recipients under calcineurin inhibitor-based immunosuppression.

Authors:  Hee Yeon Kim; Mi-La Cho; Joo Yeon Jhun; Jae Kyeong Byun; Eun-Kyung Kim; Ye Been Yim; Byung Ha Chung; Seung Kew Yoon; Si Hyun Bae; Dong Goo Kim; Chul Woo Yang; Jong Young Choi
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

Review 10.  Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.

Authors:  Nataraju Angaswamy; Venkataswarup Tiriveedhi; Nayan J Sarma; Vijay Subramanian; Christina Klein; Jason Wellen; Surendra Shenoy; William C Chapman; T Mohanakumar
Journal:  Hum Immunol       Date:  2013-07-19       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.